|
Significant subsequent events Nexi announces the start of a share buy - back program up to 500 M to be completed by October 31 st , 2025 and already approved by the Shareholders' meeting on April 30 ...
01Net
-
11 ore fa
|
|
|
|
Articoli correlati Group Financial Results as of March 31st 2024 Approved, Continued Growth and EBITDA Margin Expansion, 500 Million Share Buy - Back Program Launched Business Wire Business Wire - 9 ...
01Net
-
11 ore fa
|
|
|
|
+39 02 535761 Articoli correlati Group Financial Results as of March 31st 2024 Approved, Continued Growth and EBITDA Margin Expansion, 500 Million Share Buy - Back Program Launched Business Wire ...
01Net
-
11 ore fa
|
|
|
|
Contacts Charlotte Kelly / Mary Taylor 07891 496946 / 07539 366728 eresidency@clarity.global Articoli correlati Group Financial Results as of March 31st 2024 Approved, Continued Growth and EBITDA ...
01Net
-
11 ore fa
|
|
|
|
The first commercially approved PFA case in the U. S. was performed earlier this year by physicians at TCAI. PFA produces high - frequency electrical pulses to destroy muscle cells that cause ...
Adnkronos
-
8-5-2024
|
|
|
|
Calysta is now producing at significant scale, and FeedKind Pet is approved for use in pet foods in the EU. We are excited Dr. Clauder's is introducing a snack featuring FeedKind Pet protein as we ...
01Net
-
8-5-2024
|
|
|
|
More than 80% of borrowers are approved instantly, with zero documentation to upload. Founded in 2012, Upstart's platform includes personal loans, automotive retail and refinance loans, and small - ...
01Net
-
8-5-2024
|
|
|
|
With TalkTRx, reps can pull up the approved asset from Vault PromoMats on ACTO and review the key message points in a matter of minutes. Not only does this ensure message accuracy, it also encourages ...
Adnkronos
-
7-5-2024
|
|
|
|
This financing is expected to fund its business throughout the sale process, which is expected to be approved in July 2024. The Lender Consortium also expects to fund additional amounts to the ...
01Net
-
6-5-2024
|
|
|
|
Not cleared or approved by any global regulator for commercial availability . ii Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for ...
01Net
-
5-5-2024
|
|
|
